Endo International Ordinary Shares reported $1.19B in Cash and Equivalent for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cash And Equivalent Change
Aerie Pharmaceuticals AERI:US $ 39.44M 17M
Amarin AMRN:US $ 228M 8.85M
Ani Pharmaceuticals ANIP:US $ 63.38M 13.53M
Bristol Myers Squibb BMY:US $ 10750M 1619M
Coherus Biosciences CHRS:US $ 275.48M 50.2M
Eli Lilly And LLY:US $ 2622.9M 163.7M
Endo International Ordinary Shares ENDP:US $ 1191.57M 221.58M
Heron Therapeutics HRTX:US $ 48.61M 8.3M
Hikma Pharmaceutical HIK:LN 23M 1000K
Horizon Pharma HZNP:US $ 1892.56M 249.43M
Lannett LCI:US $ 106.11M 7.47M
Ligand Pharmaceuticals LGND:US $ 153.22M 138.22M
Novartis NOVN:VX SF 3625M 10227M
Pacira Pharmaceuticals PCRX:US $ 122.06M 104.69M
Perrigo Ordinary Shares PRGO:US $ 485.3M 1480.2M
Phibro Animal Health PAHC:US $ 70.75M 7.36M
Revance Therapeutics RVNC:US $ 69.42M 128.94M
Supernus Pharmaceuticals SUPN:US $ 173.43M 57.71M
Takeda 4502:JP Y 645991M 203704M
Teva Pharmaceutical TEVA:IT 2.06B 117M
Xeris Pharmaceuticals Inc XERS:US $ 95.34M 8.43M
Zoetis ZTS:US $ 2648M 484M